Chelsea completes enrollment for Phase II arthritis trial
A total of 200 patients were enrolled in this 12-week, four-arm, parallel group Phase II clinical trial designed comparing 0.25mg, 0.5mg and 1mg once daily oral doses of
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.
Hi-Tech’s dorzolamide ophthalmic solution is the generic for Merck’s Trusopt ophthalmic solution 2%, indicated for elevated intraocular pressure in patients with ocular hypertension or open-angel glaucoma. Hi-Tech said
In this position, Ms Perkins will continue to have responsibility for all of Infinity’s business functions, including corporate and product strategy, business development, finance, organizational development and human
This study showed that Orencia (abatacept) in combination with methotrexate (MTX) had significantly more patients achieve a disease activity score 28 using C-reactive protein [DAS28 (CRP)]-defined remission, compared